All networks

DU, Changgen

DU, Changgen is designated by OFAC under ILLICIT-DRUGS-EO14059. OFAC's published remarks link 4 further designated entries to it. Every link below is OFAC's own text, quoted verbatim; OilFlow adds no inference about ownership, control or conduct beyond what the designation states.

Head entityDU, Changgen
Head typeindividuals
Linked designated entries4
of which companies4
Programs across the network['ILLICIT-DRUGS-EO14059']

Counts are from the OilFlow snapshot of 2026-09-05 and are re-derived from the database by a check that fails on any difference. The member list below is read live.

Linked entries (4)

  1. HUBEI VAST CHEMICAL CO., LIMITEDILLICIT-DRUGS-EO14059
    OFAC remark: “(Linked To: DU, Changgen)
  2. HEBEI GUANLANG BIOTECHNOLOGY CO., LIMITEDILLICIT-DRUGS-EO14059
    OFAC remark: “(Linked To: DU, Changgen)
  3. HEBEI XIUNA TRADING CO., LTD.ILLICIT-DRUGS-EO14059
    OFAC remark: “(Linked To: DU, Changgen)
  4. SHANGHAI JARRED INDUSTRIAL CO., LTD.ILLICIT-DRUGS-EO14059
    OFAC remark: “(Linked To: DU, Changgen)

A page tells you what OFAC published about the head. A screen tells you whether the name in front of you, with its aliases and 50%-rule owners, matches any of these entries or any of the eight lists.

A dossier screens one named counterparty across all eight lists and the 50% rule, with the evidence chain.

Source: US Consolidated Screening List (public domain). Designation and remark text are OFAC's. Names on OilFlow's protected list are excluded from every network page. This is a reading of a public record and not legal advice; confirm against the primary list before acting.